LimestoneGrey has been named a finalist in the One Nucleus Awards 2026, in the Most Innovative Professional Services Company of the Year category. The shortlisting recognises our specialist work supporting the UK’s life sciences, biotech and medtech sectors.
One Nucleus is one of the UK’s leading life sciences and healthcare membership organisations, and being shortlisted by it is a significant milestone for our firm. It reflects the impact of our work within one of the country’s most innovative and research-intensive industries.
Recognising excellence in the life sciences community
The One Nucleus Awards celebrate organisations that demonstrate innovation, impact and excellence across the life sciences ecosystem. The awards bring together pioneering biotech companies, medtech developers, life sciences innovators and the professional advisers who support them.
To be recognised as a finalist in the Most Innovative Professional Services Company of the Year category places LimestoneGrey alongside some of the most exciting and forward-thinking organisations in the sector.
For us, this recognition is particularly meaningful because life sciences is a community we actively support and understand deeply, more than a market we operate in; you can read about how we work with the sector on our life sciences page.
Specialist R&D tax expertise for life sciences, biotech and medtech
LimestoneGrey’s Managing Director, Matthew Jones, comments: “The life sciences sector presents unique technical, regulatory and scientific complexities. Preparing an R&D tax claim in this space requires more than basic compliance knowledge, it requires a genuine understanding.
We are fortunate to work closely with founders, CTOs, CSOs and laboratory leads from companies striving to make a genuine difference. Our role is to ensure that R&D tax claims clearly articulate the underlying scientific or technological advance being pursued, rather than focusing solely on commercial objectives or market outcomes.
We would like to congratulate all the shortlisted companies and thank our clients and partners who continue to place their trust in LimestoneGrey. Being named a One Nucleus Awards finalist reflects our commitment to technical excellence and our deep understanding of R&D in this space.
The UK life sciences sector remains one of the most dynamic and globally competitive industries, and we are proud to play a role in supporting the innovators developing new diagnostics, therapies, technologies and platforms that improve lives.
We are looking forward to celebrating on 19th March in London.”
If you are a biotech, medtech or life sciences company looking for specialist advice on R&D tax relief, we would welcome the opportunity to talk; get in touch or read more about the firm.
This article describes the rules as they stood at the review date above. The rules change: for the current position, start with our guides or talk to us.
